FindMyKOL
Clinical trialNCT01509339WithdrawnPhase 1Interventional

Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis

SponsorCase Western Reserve UniversityEnrollment0Cystic FibrosisMethicillin-resistant Staphylococcus Aureus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the pharmacokinetics and safety of inhaled vancomycin in patients with cystic fibrosis.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Elliott C Dasenbrook, MD MHS

    Case Western Reserve University School of Medicine

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Rainbow Babies and Children'S Hospital, Univeristy Hospitals Case Medical Center

    Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2012
Primary completion
23 Dec 2021
Completion
23 Dec 2021
Last update posted
12 Jan 2022
Registered enrollment
0
Registry id
NCT01509339

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.